Early diastolic function during exertion influences exercise intolerance in patients with hypertrophic cardiomyopathy

Journal of Echocardiography

Volumn 11, Issue 1, 2013, Pages 9-17

  Mizukoshi, Kei ^a   Suzuki, Kengo ^a   Yoneyama, Kihei ^a   Kamijima, Ryo ^a   Kou, Seisyou ^a   Takai, Manabu ^a   Izumo, Masaki ^a   Hayashi, Akio ^a   Ohtaki, Eiji ^b   Akashi, Yoshihiro J ^a   Osada, Naohiko ^a   Omiya, Kazuto ^a   Harada, Tomoo ^a   Nobuoka, Sachihiko ^a   Miyake, Fumihiko ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Ohtaki Heart Clinic   (Japan)

Author keywords

Diastolic function; Exercise capacity; Exercise echocardiography; Hypertrophic cardiomyopathy; Speckle tracking echocardiography

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; ARTICLE; BICYCLE; BICYCLE ERGOMETER; CARDIOPULMONARY EXERCISE TEST; CARDIOVASCULAR PARAMETERS; CLINICAL ARTICLE; CORRELATION ANALYSIS; DIASTOLE; ECHOCARDIOGRAPHY; EXERCISE; EXERCISE TOLERANCE; FEMALE; GLOBAL LONGITUDINAL STRAIN; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LINEAR REGRESSION ANALYSIS; MALE; OXYGEN CONSUMPTION; REST; STATISTICAL ANALYSIS; SYSTOLE; TWO DIMENSIONAL SPECKLE TRACKING ECHOCARDIOGRAPHY;

EID: 84875600323     PISSN: 13490222     EISSN: 1880344X     Source Type: Journal    
DOI: 10.1007/s12574-012-0150-0     Document Type: Article

References (40)

1. Maron BJ, Bonow RO, Cannon RO 3rd, et al. Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (2). N Engl J Med. 1987; 316: 844-52.
2. Maron MS, Olivotto I, Betocchi S, et al. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med. 2003; 348: 295-303.
3. Jones S, Elliott PM, Sharma S, et al. Cardiopulmonary responses to exercise in patients with hypertrophic cardiomyopathy. Heart. 1998; 80: 60-7.
4. Sharma S, Elliott P, Whyte G, et al. Utility of cardiopulmonary exercise in the assessment of clinical determinants of functional capacity in hypertrophic cardiomyopathy. Am J Cardiol. 2000; 86: 162-8.
5. Lele SS, Thomson HL, Seo H, et al. Exercise capacity in hypertrophic cardiomyopathy. Role of stroke volume limitation, heart rate, and diastolic filling characteristics. Circulation. 1995; 92: 2886-94.
6. Chikamori T, Counihan PJ, Doi YL, et al. Mechanisms of exercise limitation in hypertrophic cardiomyopathy. J Am Coll Cardiol. 1992; 19: 507-12.
7. Podolec P, Rubís P, Tomkiewicz-Pajak L, et al. Usefulness of the evaluation of left ventricular diastolic function changes during stress echocardiography in predicting exercise capacity in patients with ischemic heart failure. J Am Soc Echocardiogr. 2008; 21: 834-40.
8. Nishimura RA, Holmes DR Jr. Clinical practice. Hypertrophic obstructive cardiomyopathy. N Engl J Med. 2004; 350: 1320-7.
9. Oh JK, Appleton CP, Hatle LK, et al. The noninvasive assessment of left ventricular diastolic function with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr. 1997; 10: 246-70.
10. Yu WC, Lee WS, Huang WP, et al. Evaluation of cardiac function by tissue Doppler echocardiography: hemodynamic determinants and clinical application. Ultrasound Med Biol. 2005; 31: 23-30.
11. Ommen SR, Nishimura RA, Appleton CP, et al. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study. Circulation. 2000; 102: 1788-94.
12. Geske JB, Sorajja P, Nishimura RA, et al. Evaluation of left ventricular filling pressures by Doppler echocardiography in patients with hypertrophic cardiomyopathy: correlation with direct left atrial pressure measurement at cardiac catheterization. Circulation. 2007; 116: 2702-8.
13. Nagueh SF, Appleton CP, Gillebert TC, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr. 2009; 22: 107-33.
14. Yoshida T, Mori M, Nimura Y, et al. Analysis of heart motion with ultrasonic Doppler method and its clinical application. Am Heart J. 1961; 61: 61-75.
15. American College of Sports Medicine. ACSM's guidelines for exercise testing and prescription: clinical exercise testing. 6th ed. Baltimore: Williams & Wilkins; 2000.
16. Kitzman DW, Higginbotham MB, Cobb FR, et al. Exercise intolerance in patients with heart failure and preserved left ventricular systolic function: failure of the Frank-Starling mechanism. J Am Coll Cardiol. 1991; 17: 1065-72.
17. Sanderson JE, Gibson DG, Brown DJ, et al. Left ventricular filling in hypertrophic cardiomyopathy. An angiographic study. Br Heart J. 1977; 39: 661-70.
18. Sanderson JE, Wang M, Yu CM. Tissue Doppler imaging for predicting outcome in patients with cardiovascular disease. Curr Opin Cardiol. 2004; 19: 458-63.
19. Gwathmey JK, Warren SE, Briggs GM, et al. Diastolic dysfunction in hypertrophic cardiomyopathy. Effect on active force generation during systole. J Clin Invest. 1991; 87: 1023-31.
20. Betocchi S, Hess OM, Losi MA, et al. Regional left ventricular mechanics in hypertrophic cardiomyopathy. Circulation. 1993; 88: 2206-14.
21. Ashrafian H, Watkins H. Myocardial dysfunction in hypertrophic cardiomyopathy. Circulation. 2001; 104: E165.
22. Abozguia K, Clarke K, Lee L, et al. Modification of myocardial substrate use as a therapy for heart failure. Nat Clin Pract Cardiovasc Med. 2006; 3: 490-8.
23. Abozguia K, Nallur Shivu G, Phan TT, et al. Potential of metabolic agents as adjunct therapies in heart failure. Future Cardiol. 2007; 3: 525-35.
24. Frank D, Frey N. Cardiac Z-disc signaling network. J Biol Chem. 2011; 286: 9897-904.
25. Gautel M. The sarcomere and the nucleus: functional links to hypertrophy, atrophy and sarcopenia. Adv Exp Med Biol. 2008; 642: 176-91.
26. Carasso S, Yang H, Woo A, et al. Systolic myocardial mechanics in hypertrophic cardiomyopathy: novel concepts and implications for clinical status. J Am Soc Echocardiogr. 2008; 21: 675-83.
27. Nagueh SF, Bachinski LL, Meyer D, et al. Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy. Circulation. 2001; 104: 128-30.
28. Cecchi F, Olivotto I, Gistri R, et al. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med. 2003; 349: 1027-35.
29. Vinereanu D, Florescu N, Sculthorpe N, et al. Differentiation between pathologic and physiologic left ventricular hypertrophy by tissue Doppler assessment of long-axis function in patients with hypertrophic cardiomyopathy or systemic hypertension and in athletes. Am J Cardiol. 2001; 88: 53-8.
30. Bolognesi R, Tsialtas D, Barilli AL, et al. Detection of early abnormalities of left ventricular function by hemodynamic, echo-tissue Doppler imaging, and mitral Doppler flow techniques in patients with coronary artery disease and normal ejection fraction. J Am Soc Echocardiogr. 2001; 14: 764-72.
31. Donal E, Coquerel N, Bodi S, et al. Importance of ventricular longitudinal function in chronic heart failure. Eur J Echocardiogr. 2011; 12: 619-27.
32. Wang J, Khoury DS, Yue Y, et al. Preserved left ventricular twist and circumferential deformation, but depressed longitudinal and radial deformation in patients with diastolic heart failure. Eur Heart J. 2008; 29: 1283-9.
33. Maron MS, Olivotto I, Zenovich AG, et al. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation. 2006; 114: 2232-9.
34. Shah JS, Esteban MT, Thaman R, et al. Prevalence of exercise-induced left ventricular outflow tract obstruction in symptomatic patients with non-obstructive hypertrophic cardiomyopathy. Heart. 2008; 94: 1288-94.
35. Maron BJ, Epstein SE. Hypertrophic cardiomyopathy. Recent observations regarding the specificity of three hallmarks of the disease: asymmetric septal hypertrophy, septal disorganization and systolic anterior motion of the anterior mitral leaflet. Am J Cardiol. 1980; 45: 141-54.
36. Nihoyannopoulos P, Karatasakis G, Frenneaux M, et al. Diastolic function in hypertrophic cardiomyopathy: relation to exercise capacity. J Am Coll Cardiol. 1992; 19: 536-40.
37. Shapiro LM, Gibson DG. Patterns of diastolic dysfunction in left ventricular hypertrophy. Br Heart J. 1988; 59: 438-45.
38. Spirito P, Maron BJ, Chiarella F, et al. Diastolic abnormalities in patients with hypertrophic cardiomyopathy: relation to magnitude of left ventricular hypertrophy. Circulation. 1985; 72: 310-6.
39. Nagueh SF, Kopelen HA, Lim DS, et al. Tissue Doppler imaging consistently detects myocardial contraction and relaxation abnormalities, irrespective of cardiac hypertrophy, in a transgenic rabbit model of human hypertrophic cardiomyopathy. Circulation. 2000; 102: 1346-50.
40. Spirito P, Maron BJ. Relation between extent of left ventricular hypertrophy and occurrence of sudden cardiac death in hypertrophic cardiomyopathy. J Am Coll Cardiol. 1990; 15: 1521-6.